Showing 6741-6750 of 9147 results for "".
- New Technology Helps Identify Two Rare Skin Cell Subtypeshttps://practicaldermatology.com/news/20120515-new_technology_helps_identify_two_rare_skin_cell_subtypes/2459799/
- Leading Melanoma Groups Unveil New Campaign Aimed at Menhttps://practicaldermatology.com/news/20120515-leading_melanoma_groups_unveil_new_campaign_aimed_at_men/2459800/
- Ulthera Cleared in Mexicohttps://practicaldermatology.com/news/20120320-ulthera_cleared_in_mexico/2459837/Ulthera is now registered in Mexico to market and distribute its ultrasound therapy device, the Ulthera System. In Mexico, the system is now prescribed to produce stimulation in tissues to raise the temperature in a localized manner for aesthetic
- Health Canada Approves BMS' Yervoy forhttps://practicaldermatology.com/news/20120208-health_canada_approves_bms_yervoy_for/2459870/
- Long-Term Dupilumab Use Linked to Delayed Relapse in AD: Studyhttps://practicaldermatology.com/news/long-term-dupilumab-use-linked-to-delayed-relapse-in-ad-study/2487027/Patients with moderate-to-severe atopic dermatitis (AD) treated with dupilumab experienced durable symptom control and delayed relapse with long-term therapy, according to a real-world retrospective study published in the Journal
- Reduced AMP Expression Seen in Sensitive Skin Syndrome: Pilot Studyhttps://practicaldermatology.com/news/reduced-amp-expression-seen-in-sensitive-skin-syndrome-pilot-study/2486974/A pilot study published in the Journal of the American Academy of Dermatology evaluated whether key pathophysiologic features of rosacea—Demodex colonization and antimicrobial peptide (AMP) dysregulation—are also present in
- Dr. Kevin Pinski Presents Injectable Pearls at Noahhttps://practicaldermatology.com/news/dr-kevin-pinski-presents-injectable-pearls-at-noah/2486902/At the 67th Noah Worcester Dermatological Society Annual Meeting, Kevin Pinski, MD, presented “Injectable Pearls,” drawing on nearly 4 decades of experience with neuromodulators, fillers, and cosmetic injectables. The presentation covered practical techniques, pati
- Analysis: PRS Improves Melanoma Risk Predictionhttps://practicaldermatology.com/news/tildrakizumab-matches-risankizumab-guselkumab-in-mid-term-psoriasis-outcomes/2486903/A polygenic risk score (PRS) improved prediction of invasive cutaneous melanoma when added to an established clinical risk model, according to findings from a recent genome-wide association analysis. The PRS was derived from a
- Incyte Reports Positive Vitiligo Phase 3 Data Supporting JAK Therapieshttps://practicaldermatology.com/news/incyte-reports-positive-vitiligo-phase-3-data-supporting-jak-pipeline/2486888/Incyte provided updated data on two therapies in its dermatology pipeline during its recent earnings call, according to a statement from the company. Ruxolitinib Update
- AQUA Announces Partnership with Steele Dermatologyhttps://practicaldermatology.com/news/aqua-announces-partnership-with-steele-dermatology/2486768/AQUA Dermatology has announced a new partnership with Steele Dermatology, expanding its presence in the Atlanta metropolitan area, according to a press release.AQUA, backed by private equity firms Gryphon Investors and GTCR, continues to scale its network